Alzheimer’s Disease (AD) is an incurable, degenerative, and terminal disease with few therapeutic options [22][23]. It is a complex disease influenced by a range of genetic, environmental, and other factors [23]. Recently, Jack et al.[24] demonstrated the value of shared data in AD biomarker research. A New York Times article on the role of data sharing, in the advancement of AD research, quotes John Trojanowski at the Uni- versity of Pennsylvania Medical School: “It’s not science the way most of us have prac- ticed it in our careers. But we all realized that we would never get biomarkers unless all of us parked our egos and intellectual-property.
